Evvy

AI precision medicine powered by the vaginal microbiome

San Francisco, United States · Founded 2021 · $59.0M raised

Employees
11–50
Founded
2021
Business Model
B2C
Website
evvy.com
Total Funding
$59.0M
Last Round
$40.0M Series BSep 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Evvy is an AI precision medicine platform for women powered by vaginal microbiome data. It operates a testing and clinical care platform intended to give women answers across vaginal health, fertility, and menopause. EvvyAI translates the company's vaginal microbiome dataset into biomarker discovery and personalized care pathways. Its mission is to close the gender health gap by using overlooked female biomarkers.

Summary

Evvy is a Life Sciences company based in San Francisco, United States, founded in 2021. It has raised $59.0M in total across 3 rounds, most recently a $40.0M Series B round in Sep 2026. Investors include General Catalyst, Left Lane Capital and RH Capital.

Tech & App Stack

10 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2026
$40.0M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Evvy on Indexed.vc
<a href="https://indexed.vc/companies/evvy"><img src="https://indexed.vc/api/badge/company/evvy" alt="Evvy on Indexed.vc" width="260" height="76" /></a>